ZIM Laboratories Limited (NSE:ZIMLAB)
68.10
+0.63 (0.93%)
Apr 6, 2026, 3:29 PM IST
ZIM Laboratories Employees
ZIM Laboratories had 577 employees as of March 31, 2025. The number of employees increased by 21 or 3.78% compared to the previous year.
Employees
577
Change (1Y)
21
Growth (1Y)
3.78%
Revenue / Employee
6.55M INR
Profits / Employee
121.02K INR
Market Cap
3.60B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 577 | 21 | 3.78% |
| Mar 31, 2024 | 556 | 31 | 5.90% |
| Mar 31, 2023 | 525 | 20 | 3.96% |
| Mar 31, 2022 | 505 | 18 | 3.70% |
| Mar 31, 2021 | 487 | -31 | -5.98% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nectar Lifesciences | 1,786 |
| Sigachi Industries | 1,507 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Ind-Swift Laboratories | 1,246 |
| Alpa Laboratories | 453 |
| Bafna Pharmaceuticals | 406 |
| Beta Drugs | 399 |
| Sakar Healthcare | 342 |
ZIM Laboratories News
- 14 days ago - Q2 2026 ZIM Laboratories Ltd Earnings Call Transcript - GuruFocus
- 7 weeks ago - Zim Laboratories Ltd (BOM:541400) Q3 2026 Earnings Call Highlights: Strong Export Growth Amid ... - GuruFocus
- 7 weeks ago - Q3 2026 ZIM Laboratories Ltd Earnings Call Transcript - GuruFocus
- 4 months ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 8 months ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 9 months ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn